Current Studies

PharmQuest partners with various pharmaceutical companies and is constantly acquiring new clinical trials. A list of current and tentative studies is provided on this page. Just click on the study that interests you and click the “Apply” button to send us your information. We will contact you soon to provide more information about the study and see if you qualify.

Thanks for your interest!

Asthma
Apply for Study

Study for Adults with Type 2 Diabetes

AstraZeneca has initiated the Solstice study, a global Phase 2 clinical trial evaluating an investigational type 2 diabetes medication in adults. You may be eligible to participate in this study if you:

  • Are at least 18 years old
  • Have been diagnosed with type 2 diabetes for at least 6 months
  • Have an HbA1c between 7% and 10.5%, inclusive, despite treatment with diet and exercise alone, or in combination with metformin or a SGLT2 inhibitor medication
  • Have a BMI of 23 or higher
  • Have not taken any weight loss medications in the past 3 months
  • Have not had, and are not planning to have bariatric surgery or fitting of a weight loss device
  • Do not have type 1 diabetes

Additional criteria will be assessed to confirm eligibility.

When you eat, your body releases a hormone called GLP-1 that signals a feeling of fullness, delays gastric (stomach) emptying, and lowers blood sugar levels. The investigational drug, AZD5004, has been designed to work like GLP-1 to help lower blood sugar levels and promote weight loss.

People in the Solstice study will take either AZD5004, an approved oral diabetes medication called semaglutide, or placebo tablet(s) once a day for up to 26 weeks (approximately 6 months). There is a higher chance of receiving AZD5004 or semaglutide than placebo while in the study.